Innovo Therapeutics vs Orum Therapeutics

Innovo Therapeutics logo

Innovo Therapeutics

Innovating Novel Cancer Treatments by Eliminating Cancer-Causing Proteins

9 employees · est. 2021 · San Diego, United States

VS
Orum Therapeutics logo

Orum Therapeutics

A public biotechnology company pioneering a novel class of protein degraders

55 employees · est. 2016 · Lexington, United States

Orum Therapeutics is the older company (2021 vs 2016); Orum Therapeutics is the larger of the two.

Side-by-Side Comparison

Innovo Therapeutics Orum Therapeutics
Founded
2021 2016 older
Headquarters
San Diego, United States Lexington, United States
Employees
9 55 larger
Industry
Biotechnology Biotechnology, Health Care, Health and Wellness
Funding Stage
Seed IPO
Total Funding
$200.00M $330.75M
Funding Rounds
2 7
Services
Development of transformative therapies, Addressing unmet medical needs Drug Candidate Development, Pipeline Innovation, Protein Degrader Technology, Novel Drug Discovery
Target Customers
Patients with unmet medical needs, Healthcare providers, Medical researchers Healthcare Providers, Pharmaceutical Companies, Research Institutions, Investors
Taxonomy
Protein DegradationDrug DiscoveryTargeted TherapiesOncologyBiopharmaceuticalsNovel Cancer Treatments +9 Clinical StageOncologyCancerProtein DegradationAntibody TherapyDrug Development +8
Website
innovotherapeutics.com orumrx.com
Innovo Therapeutics logo

About Innovo Therapeutics

Innovo Therapeutics, founded in 2021, is a biotechnology startup headquartered in the United States. With a mission captured by its slogan, "Innovating Novel Cancer Treatments by Eliminating Cancer-Causing Proteins," the company is focused on developing next-generation protein degraders targeting ar...

Orum Therapeutics logo

About Orum Therapeutics

Orum Therapeutics is a public biotechnology company known for pioneering a novel class of protein degraders. As a key player in Biotechnology and Health Care, it has introduced TPD2®, a breakthrough in targeted protein degradation therapeutics described as degrader-antibody conjugates (DACs). These...

Also comparing in this category

We will tell you when either one moves

BounceWatch watches Innovo Therapeutics and Orum Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, it is in your next e-mail.

Get notified when Innovo Therapeutics or Orum Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

Frequently Asked Questions

Innovo Therapeutics was founded in 2021, based in San Diego, United States, with 9 employees. Innovo Therapeutics, founded in 2021, is a biotechnology startup headquartered in the United States. With a mission captured by its slogan, "Innovating Novel Cancer Treatments by Eliminating Cancer-Ca. Orum Therapeutics was founded in 2016, based in Lexington, United States, with 55 employees. Orum Therapeutics is a public biotechnology company known for pioneering a novel class of protein degraders. As a key player in Biotechnology and Health Care, it has introduced TPD2®, a breakthrough i.
Innovo Therapeutics has raised $200.00M and Orum Therapeutics $330.75M. Latest stage: Innovo Therapeutics Seed, Orum Therapeutics IPO.
Both work in Biotechnology and list protein degradation, oncology and antibody therapy among their focus areas.

Compare Innovo Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Innovo Therapeutics on 31 Mar 2026, and Orum Therapeutics on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes